Alvotinib has the main ingredient Imatinib, which is made in the form of film-coated tablets. It is indicated for the treatment of leukemia, Hypereosinophilic syndrome and inoperable gastrointestinal malignancies.

Umkanib is made in the form of tablets, with the main ingredient being Imatinib. The drug is used in the treatment of chronic lymphocytic leukemia and myeloid leukemia.